文献速递帕金森病与运动障碍认知障碍与痴呆

路易体病中淀粉样蛋白与多巴胺转运体影像的神经病理关联

Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.
PubMed 文献 · Neurology · 2019-06-26

本研究对18例路易体谱系患者(4例认知正常帕金森病、4例帕金森病伴认知障碍、10例路易体痴呆)进行[11C]PiB淀粉样蛋白成像和[11C]Altropane多巴胺转运体成像,并与尸检神经病理对照。结果显示[11C]Altropane PET可敏感反映黑质变性,[11C]PiB摄取准确反映皮质淀粉样沉积,且与神经炎性斑块、神经原纤维缠结及路易体病理严重程度相关。

要点

  • [11C]Altropane PET是黑质变性的敏感指标。
  • [11C]PiB扫描准确反映尸检皮质淀粉样沉积。
  • 分子影像支持用于路易体病评估。

核心结论

  • 生前[11C]Altropane PET是黑质变性的敏感测量方法。
  • [11C]PiB扫描准确反映尸检所见的皮质淀粉样沉积。
  • 这些发现支持分子影像用于路易体病患者评估。

研究设计与样本

  • 纳入4例认知正常帕金森病、4例帕金森病伴认知障碍和10例路易体痴呆患者。
  • 所有18例接受[11C]PiB淀粉样蛋白成像和[11C]Altropane多巴胺转运体成像。
  • 所有18例每年进行神经科检查,并接受尸检神经病理评估。
  • 神经病理评估包括Braak路易体分期、Thal淀粉样分布、CERAD神经炎性斑块、Braak神经原纤维缠结和脑淀粉样血管病,以及四个皮质区域总淀粉样斑块负荷。
  • PET数据以小脑为参考表达为标准摄取值比,分析时考虑成像与尸检间隔。

主要发现

  • 所有18例均符合路易体病神经病理标准,且每例DAT浓度均低。
  • 所有新皮质聚合[11C]PiB保留升高患者尸检均有β-淀粉样沉积。
  • [11C]PiB保留与神经炎性斑块负荷及总斑块负荷显著相关。
  • [11C]PiB保留与Braak神经原纤维缠结分期和路易体评分严重程度均显著相关。
  • 神经炎性斑块负荷与神经原纤维缠结病理显著相关。

临床怎么用

  • 在路易体谱系疾病评估中,可考虑使用[11C]Altropane PET评估黑质变性。
  • 可使用[11C]PiB PET评估皮质淀粉样沉积,其结果与尸检病理相符。
  • 分子影像有助于在生前综合评估路易体病患者的病理负荷。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop imaging biomarkers of diseases in the Lewy body spectrum and to validate these markers against postmortem neuropathologic findings. METHODS: Four cognitively normal participants with Parkinson disease (PD), 4 with PD with cognitive impairments, and 10 with dementia with Lewy bodies underwent amyloid imaging with [11C]Pittsburgh compound B (PiB) and dopamine transporter (DAT) imaging with [11C]Altropane. All 18 had annual neurologic examinations. All cognitively normal participants with PD developed cognitive impairment before death. Neuropathologic examinations assessed and scored Braak Lewy bodies, Thal distribution of amyloid, Consortium to Establish a Registry for Alzheimer's Disease neuritic amyloid plaques, Braak neurofibrillary tangles, and cerebral amyloid angiopathy, as well as total amyloid plaque burden in the superior frontal, superior parietal, occipital, and inferior temporal cortical regions. PET data were expressed as the standardized uptake value ratio with cerebellar reference. Analyses accounted for the interval between imaging and autopsy. RESULTS: All 18 patients met neuropathologic criteria for Lewy body disease; the DAT concentration was low in each case. All patients with elevated [11C]PiB retention measured in a neocortical aggregate had β-amyloid deposits at autopsy. [11C]PiB retention significantly correlated with neuritic plaque burden and with total plaque burden. [11C]PiB retention also significantly correlated with the severity of both Braak stages of neurofibrillary tangle and Lewy body scores. Neuritic plaque burden was significantly associated with neurofibrillary tangle pathology. CONCLUSION: Antemortem [11C]Altropane PET is a sensitive measure of substantia nigra degeneration. [11C]PiB scans accurately reflect cortical amyloid deposits seen at autopsy. These findings support the use of molecular imaging in the evaluation of patients with Lewy body diseases.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Shirvan J, Clement N, Ye R, et al. Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease. Neurology. 2019. PMID: 31243072. doi:10.1212/WNL.0000000000007855

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。